Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $47.23M.
ENTERPRISE VALUE (EV)
$47.23M
Apollomics, Inc.
Market Cap
$50.51M
Enterprise Value (EV)
$47.23M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Apollomics, Inc. (APLM) | $50.51M | $47.23M |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | $31.38M |
| Clene Inc. (CLNN)vs › | $49.96M | $62.64M |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | $41.63M |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | $46.67M |
| Celularity Inc. (CELU)vs › | $49.50M | $109.43M |
| INmune Bio, Inc. (INMB)vs › | $51.58M | $34.57M |
| biote Corp. (BTMD)vs › | $49.40M | $166.87M |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A |
Market Cap
$50.51M
Total Debt
$0.00
Cash
$3.28M
Enterprise Value
$47.23M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
